NanoInk,(R) Inc. announced today that it has initiated a process to evaluate the company's strategic alternatives with the assistance of its financial advisor, Lazard. NanoInk is the leader in next-generation nanolithography and has been developing and commercializing disruptive nanoscale products and applications for the life sciences and technology industries.
In life sciences, the company's technology is currently being applied to proteomics, diagnostics, cell biology and other areas. NanoInk's patent portfolio includes more than 100 issued patents and nearly 250 patent applications worldwide covering their next-generation nanolithography.
Due to the broad applicability of NanoInk's technology across multiple industries, the company is considering a range of strategic alternatives including, but not limited to, a sale of the company, a sale of specific DPN(R) applications and/or the NanoGuardian(TM) business, or partnerships around NanoInk's technology.
James M. Hussey, CEO of NanoInk said, "Our next-generation nanolithography technology has experienced robust sales growth and expansion into new applications, particularly in the life sciences. NanoInk is pleased to work with Lazard to secure the optimal structure for rapid and broad proliferation of our technology worldwide."
About NanoInk NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the life sciences, engineering, pharmaceutical, and education industries. Using Dip Pen Nanolithography(R) (DPN(R)), a patented and proprietary nanofabrication technology, scientists are enabled to rapidly and easily create microscale and nanoscale structures from a variety of materials on a range of substrates. This low cost, easy to use and scalable technique brings sophisticated nanofabrication to many commercial market segments.
Headquartered in the Illinois Science + Technology Park, north of Chicago, NanoInk currently has nearly 350 patents and applications filed worldwide and licensing agreements with many world class universities including Northwestern, Stanford and the University of Illinois. For more information on products and services offered by NanoInk, Inc., visit www.nanoink.net .
Divisions of NanoInk: The NanoFabrication Systems Division provides core desktop instrumentation and application expertise for current and future applications of DPN.
The Nano BioDiscovery Division provides instruments, assay kits, and contract services for nanoscale protein detection using DPN technology.
The NanoStem Cell Division aims to revolutionize the utility of stem cells through the application of DPN nanopatterning.
The NanoProfessor(TM) Division provides a complete nanotechnology educational solution including a suite of instruments, interdisciplinary-based curriculum, cutting-edge labs, and comprehensive educator and program support developed to extend hands-on nanotechnology education to the undergraduate classroom.
The NanoGuardian(TM) Division uses NanoEncryption(TM) technology to offer pharmaceutical customers a state-of-the-art on-dose brand security solution to fight counterfeiting and illegal diversion.
NanoInk, the NanoInk logo, Dip Pen Nanolithography, DPN, and NanoProfessor are trademarks or registered trademarks of NanoInk, Inc.